Trails Edge Capital Partners, Lp Top Holdings and 13F Report (2026) About Trails Edge Capital Partners, LpInvestment ActivityTrails Edge Capital Partners, Lp has $629.91 million in total holdings as of June 30, 2026.Trails Edge Capital Partners, Lp owns shares of 35 different stocks, but just 20 companies or ETFs make up 80% of its holdings.Approximately 44.14% of the portfolio was purchased this quarter.About 25.84% of the portfolio was sold this quarter.This quarter, Trails Edge Capital Partners, Lp has purchased 26 new stocks and bought additional shares in 10 stocks.Trails Edge Capital Partners, Lp sold shares of 8 stocks and completely divested from 4 stocks this quarter.Largest Holdings LB PHARMACEUTICALS INC $49,429,679Nurix Therapeutics $38,166,318Immunocore $33,757,680FIRST TRACKS BIOTHERAPEUTICS $30,461,6804D Molecular Therapeutics $29,631,296 Largest New Holdings this Quarter 337185102 - FIRST TRACKS BIOTHERAPEUTICS $30,461,680 Holding09061G101 - BioMarin Pharmaceutical $29,296,640 Holding457669307 - Insmed $24,557,891 Holding482931102 - KAILERA THERAPEUTICS INC $21,694,836 Holding45337C102 - Incyte $17,570,800 Holding Largest Purchases this Quarter FIRST TRACKS BIOTHERAPEUTICS 1,514,000 shares (about $30.46M)BioMarin Pharmaceutical 512,000 shares (about $29.30M)Insmed 230,331 shares (about $24.56M)KAILERA THERAPEUTICS INC 984,786 shares (about $21.69M)Incyte 155,000 shares (about $17.57M) Largest Sales this Quarter Revolution Medicines 129,250 shares (about $24.21M)Mirum Pharmaceuticals 110,000 shares (about $12.88M)Xenon Pharmaceuticals 200,000 shares (about $12.07M)Nurix Therapeutics 170,000 shares (about $4.12M)NEUROGENE INC 67,902 shares (about $2.14M) Sector Allocation Over TimeMap of 500 Largest Holdings ofTrails Edge Capital Partners, Lp Selling Neutral Buying Latest 13F Holdings and Changes Since Previous Quarterly FilingIssuer NameHoldings ValueApproximate Purchase/SaleChange in SharesShares Held% of PortfolioSectorLB PHARMACEUTICALS INC$49,429,679$6,609,785 â–²15.4%1,523,0227.8%COM SHSNRIXNurix Therapeutics$38,166,318$4,124,200 â–¼-9.8%1,573,2206.1%HealthcareIMCRImmunocore$33,757,680$12,085,225 â–²55.8%1,063,2345.4%HealthcareFIRST TRACKS BIOTHERAPEUTICS$30,461,680$30,461,680 â–²New Holding1,514,0004.8%ORD SHSFDMT4D Molecular Therapeutics$29,631,296$12,302,500 â–²71.0%2,227,9174.7%HealthcareBMRNBioMarin Pharmaceutical$29,296,640$29,296,640 â–²New Holding512,0004.7%HealthcareDSGNDesign Therapeutics$28,958,550$16,629,922 â–²134.9%2,001,2824.6%HealthcareXENEXenon Pharmaceuticals$26,558,400$12,072,000 â–¼-31.3%440,0004.2%HealthcareMIRMMirum Pharmaceuticals$26,143,136$12,877,700 â–¼-33.0%223,3124.2%HealthcareINSMInsmed$24,557,891$24,557,891 â–²New Holding230,3313.9%HealthcareCYTKCytokinetics$24,542,302$1,014,698 â–¼-4.0%288,0893.9%HealthcareSNDXSyndax Pharmaceuticals$24,264,600$8,922,793 â–²58.2%1,110,0003.9%HealthcareNEUROGENE INC$22,483,133$2,135,518 â–¼-8.7%714,8853.6%COMKAILERA THERAPEUTICS INC$21,694,836$21,694,836 â–²New Holding984,7863.4%COMMON STOCKRVMDRevolution Medicines$21,677,660$24,205,940 â–¼-52.8%115,7503.4%HealthcareINHIBIKASE THERAPEUTICS INC$18,374,176$2,017,765 â–²12.3%9,051,3182.9%COM NEWINCYIncyte$17,570,800$17,570,800 â–²New Holding155,0002.8%HealthcareAVALO THERAPEUTICS INC$16,481,961$16,481,961 â–²New Holding891,8812.6%COM NEWMLTXMoonLake Immunotherapeutics$14,602,500$14,602,500 â–²New Holding750,0002.3%HealthcareFAETH THERAPEUTICS INC$12,883,375$9,758,375 â–²312.3%515,3352.0%COM NEWX4 PHARMACEUTICALS INC$12,008,8030.0%2,571,4781.9%COM NEWOPUS GENETICS INC$11,276,434$9,221,434 â–²448.7%2,743,6581.8%COMSOL-GEL TECHNOLOGIES LTD$10,338,452$3,999,779 â–²63.1%139,4451.6%SHS NEWAURAAura Biosciences$10,247,665$10,247,665 â–²New Holding1,443,3331.6%HealthcareIPSCCentury Therapeutics$10,130,674$4,128,191 â–²68.8%4,134,9691.6%HealthcareIVAInventiva$10,047,2280.0%2,657,9971.6%HealthcareCAMP4 THERAPEUTICS CORP$8,446,935$28,956 â–¼-0.3%1,932,9371.3%COMALTAltimmune$8,086,400$8,086,400 â–²New Holding2,660,0001.3%HealthcareNERVMinerva Neurosciences$7,875,4500.0%1,419,0001.3%HealthcarePROMIS NEUROSCIENCES INC$7,331,4750.0%557,1031.2%COM SHSONKURE THERAPEUTICS INC$6,559,359$6,559,359 â–²New Holding1,438,4561.0%COM CL AFORTE BIOSCIENCES INC$5,805,097$5,805,097 â–²New Holding273,1810.9%COM NEWRESEARCH ALLIANCE CORP III$5,350,000$5,350,000 â–²New Holding500,0000.8%ORD SHS CL AVTV THERAPEUTICS INC$3,207,479$2,047,633 â–¼-39.0%85,1920.5%CL A NEWIMAGENEBIO INC$1,663,824$1,663,824 â–²New Holding282,0040.3%COMPCVXVaxcyte$0$38,496,132 â–¼-100.0%00.0%HealthcareDEFINIUM THERAPEUTICS INC$0$32,850,280 â–¼-100.0%00.0%COM SHSRCUSArcus Biosciences$0$22,635,396 â–¼-100.0%00.0%HealthcareIMVTImmunovant$0$10,285,102 â–¼-100.0%00.0%HealthcareShowing largest 100 holdings. View all holdings. More Institutional Buying and Selling Information SEC Filings and Trading Data SEC Filings 13F Filings Top 13F Buys Top 13F Sells Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.